Show simple item record

dc.contributor.author Tabaranu, Doinița
dc.date.accessioned 2020-10-16T05:12:27Z
dc.date.available 2020-10-16T05:12:27Z
dc.date.issued 2020
dc.identifier.citation TABARANU, Doinița. Diagnosis and treatment of benign breast tumors. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 67-68. en_US
dc.identifier.uri https://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/12194
dc.description Department of General Surgery and Semiology no. 3, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020 en_US
dc.description.abstract Introduction. Breast cancer is detected 3-5 times more frequently in the background of benign mammary glands pathology and 30-40 times more frequently in the background of nodular mastopathies with epithelial proliferation of the mammary glands. The early diagnosis and treatment of these tumors is of incontestable actuality. Aim of the study. Assessment of the algorithm for diagnosis and treatment of benign breast tumors in women. Materials and methods. The study represents a retrospective analysis based on the hospital medical records of 80 patients, diagnosed and treated in the department of Mammology no.1 of the Oncological Institute of the Republic of Moldova during January-March 2018. All patients were evaluated in terms of age, risk factors, comorbidities, ultrasound scan and mammography findings, cytology, radiography, histological distribution of the benign processes of the mammary gland (International Classification N 2, Edition II, Geneva, 1984), surgical techniques used, postoperative complications. Results. Thus, 80 women aged 18-65 years with different histological types of benign mammary tumors: fibroadenoma – 34 (42.5%); adenopapiloma cyst – 12 (15%); fibroadenomatoza – 17 (21.25%); lipogranuloma – 16 (20%); phylloid tumors – 1 (1.25%). Women aged 18-35 years – 26 (32.5%) and 36-65 years – 54 (67.5%). The ratio of left/right breast gland lesions was 34/43 (42.5/53.75%), bilateral affection – 3 (3.75%). The following risk factors were identified in 57 (71,25%) patients: abortions – 23 (40,35%); nulliparous – 23 (40,35%); mechanical trauma – 4 (7,01%); pelvic inflammatory disease – 3 (5,26%); uterine myoma 2 (3,5%); hereditary factors – 2 (3,5%). Significant comorbidities were found in 11 patients. All patients underwent ultrasound scan, chest x-ray, mammography in 2 projections, as well as cytological examination. All patients underwent sectoral resections with the emergency frozen-section pathological examination, followed by repeated morphological study after inclusion in paraffin. In 2 cases repeated morphological examination revealed invasive breast carcinomas, which were resected subsequently. There were no any postoperative complications. Conclusions. The diagnosis of benign breast tumors is a complex one and includes several consecutive stages. Surgical procedure depends on the nosological form of tumor and isaccompanied necessarily by urgent frozen-section pathological examination, followed by repeated morphological study after inclusion in paraffin. Key words: benign breast tumor, diagnosis, treatment. en_US
dc.language.iso en en_US
dc.publisher MedEspera en_US
dc.subject benign breast tumor en_US
dc.subject diagnosis en_US
dc.subject treatment en_US
dc.title Diagnosis and treatment of benign breast tumors en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2020
    The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics